SARM1
NAD(+) hydrolase SARM1
Also known as: KIAA0524, SAMD2, SARM, SARM1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6SZW1
- Gene
- SARM1
- Ensembl
- ENSG00000004139
- Chromosome
- 17
- Canonical length
- 724 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homooctamer
OverviewNCBI Gene
Enables NAD+ nucleosidase activity; NAD+ nucleosidase activity, cyclic ADP-ribose generating; and identical protein binding activity. Involved in NAD catabolic process and response to axon injury. Is active in mitochondrion. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
724 residues, UniProt reviewed canonical sequence.
>Q6SZW1|SARM1
1 MVLTLLLSAY KLCRFFAMSG PRPGAERLAV PGPDGGGGTG PWWAAGGRGP REVSPGAGTE
61 VQDALERALP ELQQALSALK QAGGARAVGA GLAEVFQLVE EAWLLPAVGR EVAQGLCDAI
121 RLDGGLDLLL RLLQAPELET RVQAARLLEQ ILVAENRDRV ARIGLGVILN LAKEREPVEL
181 ARSVAGILEH MFKHSEETCQ RLVAAGGLDA VLYWCRRTDP ALLRHCALAL GNCALHGGQA
241 VQRRMVEKRA AEWLFPLAFS KEDELLRLHA CLAVAVLATN KEVEREVERS GTLALVEPLV
301 ASLDPGRFAR CLVDASDTSQ GRGPDDLQRL VPLLDSNRLE AQCIGAFYLC AEAAIKSLQG
361 KTKVFSDIGA IQSLKRLVSY STNGTKSALA KRALRLLGEE VPRPILPSVP SWKEAEVQTW
421 LQQIGFSKYC ESFREQQVDG DLLLRLTEEE LQTDLGMKSG ITRKRFFREL TELKTFANYS
481 TCDRSNLADW LGSLDPRFRQ YTYGLVSCGL DRSLLHRVSE QQLLEDCGIH LGVHRARILT
541 AAREMLHSPL PCTGGKPSGD TPDVFISYRR NSGSQLASLL KVHLQLHGFS VFIDVEKLEA
601 GKFEDKLIQS VMGARNFVLV LSPGALDKCM QDHDCKDWVH KEIVTALSCG KNIVPIIDGF
661 EWPEPQVLPE DMQAVLTFNG IKWSHEYQEA TIEKIIRFLQ GRSSRDSSAG SDTSLEGAAP
721 MGPTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SARM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 8.9 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 8.9 nTPM
- duodenum: 7.1 nTPM
- pancreas: 6.9 nTPM
- retina: 6.5 nTPM
- pituitary gland: 5.6 nTPM
- adrenal gland: 5.5 nTPM
Single-cell type
- kupffer cells: 55 nCPM
- oligodendrocyte progenitor cells: 50 nCPM
- brain inhibitory neurons: 45 nCPM
- other brain neurons: 42 nCPM
- brain excitatory neurons: 42 nCPM
- retinal bipolar cells: 40 nCPM
Immune cell
- non-classical monocyte: 0.5 nTPM
- T-reg: 0.4 nTPM
- memory CD4 T-cell: 0.3 nTPM
- memory CD8 T-cell: 0.3 nTPM
- naive CD8 T-cell: 0.3 nTPM
- NK-cell: 0.3 nTPM
Brain region
- cerebellum: 20 nTPM
- cerebral cortex: 13 nTPM
- amygdala: 13 nTPM
- hippocampal formation: 13 nTPM
- basal ganglia: 13 nTPM
- thalamus: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.14
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.9
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- innate immune response
- modification of postsynaptic structure
- NAD+ catabolic process
- nervous system development
- nervous system process
- protein localization to mitochondrion
- regulation of dendrite morphogenesis
- regulation of neuron apoptotic process
- regulation of synapse pruning
- response to axon injury
- response to glucose
- signal transduction
- negative regulation of MyD88-independent toll-like receptor signaling pathway
Molecular functions
- identical protein binding
- NAD+ nucleosidase activity, cyclic ADP-ribose generating
- signaling adaptor activity
- NAD+ nucleosidase activity
- NADP+ nucleosidase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Toll/interleukin-1 receptor homology (TIR) domain
- Sterile alpha motif domain
- Armadillo-like helical
- Sterile alpha motif/pointed domain superfamily
- Armadillo-type fold
- Toll/interleukin-1 receptor homology (TIR) domain superfamily
- SAM domain (Sterile alpha motif)
- TIR domain
- Sterile alpha and TIR motif-containing protein 1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SARM1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SARM1 as an antibody target. Whether an autoantibody or antibody against SARM1 could matter depends on whether native SARM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SARM1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SARM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...